ABSTRACT
The emergence of new therapeutic modalities requires complementary tools for their efficient syntheses. Availability of methodologies for site-selective modification of biomolecules remains a long-standing challenge, given the inherent complexity and the presence of repeating residues that bear functional groups with similar reactivity profiles. We describe a bioconjugation strategy for modification of native peptides relying on high site selectivity conveyed by enzymes. We engineered penicillin G acylases to distinguish among free amino moieties of insulin (two at amino termini and an internal lysine) and manipulate cleavable phenylacetamide groups in a programmable manner to form protected insulin derivatives. This enables selective and specific chemical ligation to synthesize homogeneous bioconjugates, improving yield and purity compared to the existing methods, and generally opens avenues in the functionalization of native proteins to access biological probes or drugs.
Subject(s)
Insulin , Penicillin Amidase , Peptides , Protein Engineering , Amino Acid Sequence , Humans , Insulin/analogs & derivatives , Insulin/biosynthesis , Lysine/chemistry , Penicillin Amidase/chemistry , Penicillin Amidase/genetics , Peptides/chemistry , Peptides/genetics , Protein Engineering/methodsABSTRACT
Single-stranded silencing RNAs (ss siRNA), while not as potent as duplex RNAs, have the potential to become a novel platform technology in RNA interference based gene silencing by virtue of their simplicity and plausibly favorable characteristics in pharmacokinetics and biodistribution. Like other therapeutic pharmaceutical agents, ss siRNA can be optimized to achieve higher potency through a structure-activity based approach. Systematic chemical modification at each position of a 21-mer oligonucleotide identified 2',5'-linked 3'-deoxythymidine (3dT) at position 1 and locked nucleic acids (LNAs) at the seed region as key components to afford significant enhancement in knockdown activity both in vitro and in vivo. Further optimization by additional chemical modifications should enable ss siRNA as an alternative gene silencing modality.
Subject(s)
Gene Silencing , RNA, Messenger/genetics , RNA, Small Interfering/genetics , beta Catenin/genetics , HEK293 Cells , HumansABSTRACT
Small interfering RNA (siRNA)-mediated silencing requires siRNA loading into the RNA-induced silencing complex (RISC). Presence of 5'-phosphate (5'-P) is reported to be critical for efficient RISC loading of the antisense strand (AS) by anchoring it to the mid-domain of the Argonaute2 (Ago2) protein. Phosphorylation of exogenous duplex siRNAs is thought to be accomplished by cytosolic Clp1 kinase. However, although extensive chemical modifications are essential for siRNA-GalNAc conjugate activity, they can significantly impair Clp1 kinase activity. Here, we further elucidated the effect of 5'-P on the activity of siRNA-GalNAc conjugates. Our results demonstrate that a subset of sequences benefit from the presence of exogenous 5'-P. For those that do, incorporation of 5'-(E)-vinylphosphonate (5'-VP), a metabolically stable phosphate mimic, results in up to 20-fold improved in vitro potency and up to a threefold benefit in in vivo activity by promoting Ago2 loading and enhancing metabolic stability.
Subject(s)
Acetylgalactosamine/chemistry , Organophosphonates/chemistry , RNA Interference , RNA, Small Interfering/chemistry , Vinyl Compounds/chemistry , Animals , Apolipoproteins B/antagonists & inhibitors , Apolipoproteins B/genetics , Apolipoproteins B/metabolism , Argonaute Proteins/antagonists & inhibitors , Argonaute Proteins/genetics , Argonaute Proteins/metabolism , Cells, Cultured , Factor IX/antagonists & inhibitors , Factor IX/genetics , Factor IX/metabolism , Hepatocytes/cytology , Hepatocytes/drug effects , Hepatocytes/metabolism , Humans , Lipoproteins, LDL/blood , Mice , Mice, Inbred C57BL , Organophosphonates/pharmacology , RNA, Small Interfering/metabolism , RNA-Binding Proteins , RNA-Induced Silencing Complex/chemistry , RNA-Induced Silencing Complex/metabolism , Transcription Factors/metabolism , Vinyl Compounds/pharmacologyABSTRACT
The realization of polymer conjugate-based RNA delivery as a clinical modality requires the development and optimization of novel formulations. Although many literature examples of polymer conjugate-based SiRNA delivery systems exist, the protocols described herein represent a robust and facile way of screening any poly(amine)-based polymer system for SiRNA delivery. In this chapter, we describe the synthetic methods used to prepare poly(amide) polymers using a controlled polymerization method, as well as the preparation of the resulting targeted SiRNA polymer conjugates. In addition, detailed methods are provided for the characterization of the biodegradable poly(peptides) as well as the polymer conjugate that ensues.
Subject(s)
Drug Carriers/chemistry , Liver/metabolism , Nylons/chemistry , RNA, Small Interfering/chemistry , Amines/chemistry , Drug Carriers/chemical synthesis , Drug Carriers/metabolism , Hepatocytes/metabolism , Liver/cytology , Nylons/chemical synthesis , Nylons/metabolism , Ornithine/chemistry , Phenylalanine/chemistry , Polyethylene Glycols/chemistry , RNA, Small Interfering/metabolism , Succinimides/chemistry , Sulfides/chemistryABSTRACT
The greatest challenge standing in the way of effective in vivo siRNA delivery is creating a delivery vehicle that mediates a high degree of efficacy with a broad therapeutic window. Key structure-activity relationships of a poly(amide) polymer conjugate siRNA delivery platform were explored to discover the optimized polymer parameters that yield the highest activity of mRNA knockdown in the liver. At the same time, the poly(amide) backbone of the polymers allowed for the metabolism and clearance of the polymer from the body very quickly, which was established using radiolabeled polymers to demonstrate the time course of biodistribution and excretion from the body. The fast degradation and clearance of the polymers provided for very low toxicity at efficacious doses, and the therapeutic window of this poly(amide)-based siRNA delivery platform was shown to be much broader than a comparable polymer platform. The results of this work illustrate that the poly(amide) platform has a promising future in the development of a siRNA-based drug approved for human use.
Subject(s)
Biocompatible Materials/chemical synthesis , Drug Carriers/chemical synthesis , Liver/metabolism , Nylons/chemical synthesis , Peptides/chemical synthesis , RNA, Small Interfering/administration & dosage , Animals , Autoradiography , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacokinetics , Biocompatible Materials/toxicity , Drug Carriers/chemistry , Drug Carriers/pharmacokinetics , Drug Carriers/toxicity , Drug Design , Drug Stability , Female , Hep G2 Cells , Hepatocytes/metabolism , Humans , Liver/diagnostic imaging , Macaca mulatta , Nylons/chemistry , Nylons/pharmacokinetics , Nylons/toxicity , Peptides/chemistry , Peptides/pharmacokinetics , Peptides/toxicity , RNA, Small Interfering/genetics , RNA, Small Interfering/pharmacokinetics , RNA, Small Interfering/toxicity , Radionuclide Imaging , Rats, Sprague-Dawley , Species Specificity , Structure-Activity Relationship , Tissue DistributionABSTRACT
Polymer based carriers that aid in endosomal escape have proven to be efficacious siRNA delivery agents in vitro and in vivo; however, most suffer from cytotoxicity due in part to a lack of selectivity for endosomal versus cell membrane lysis. For polymer based carriers to move beyond the laboratory and into the clinic, it is critical to find carriers that are not only efficacious, but also have margins that are clinically relevant. In this paper we report three distinct categories of polymer conjugates that improve the selectivity of endosomal membrane lysis by relying on the change in pH associated with endosomal trafficking, including incorporation of low pKa heterocycles, acid cleavable amino side chains, or carboxylic acid pH sensitive charge switches. Additionally, we determine the therapeutic index of our polymer conjugates in vivo and demonstrate that the incorporation of pH responsive elements dramatically expands the therapeutic index to 10-15, beyond that of the therapeutic index (less than 3), for polymer conjugates previously reported.
Subject(s)
Hydrogen-Ion Concentration , Polymers/therapeutic use , RNA, Small Interfering/therapeutic use , Animals , Polymers/chemistry , Polymers/pharmacokinetics , RNA, Small Interfering/chemistry , RNA, Small Interfering/pharmacokinetics , RatsABSTRACT
We describe the synthesis of a polycatenated cyclic polymer, a structure that resembles a molecular charm bracelet. Ruthenium-catalyzed ring-opening metathesis polymerization of an amino-containing cyclic olefin monomer in the presence of a chain transfer agent generated an alpha,omega-diazide functionalized polyamine. Cyclization of the resulting linear polyamine using pseudo-high-dilution copper-catalyzed click cyclization produced a cyclic polymer in 19% yield. The click reaction was then further employed to remove linear contaminants from the cyclic polymer using azide- and alkyne-functionalized scavenging resins, and the purified cyclic polymer product was characterized by gel permeation chromatography, (1)H NMR spectroscopy, and IR spectroscopy. Polymer hydrogenation and conversion to the corresponding polyammonium species enabled coordination and interlocking of diolefin polyether fragments around the cyclic polymer backbone using ruthenium-catalyzed ring-closing olefin metathesis to afford a molecular charm bracelet structure. This charm bracelet complex was characterized by (1)H NMR spectroscopy, and the catenated nature of the small rings was confirmed using two-dimensional diffusion-ordered NMR spectroscopy.
ABSTRACT
Hydrazines and hydroxylamines have been found to be excellent nucleophiles for the palladium-catalyzed dynamic asymmetric allylic amination of vinyl epoxide, with good yields and enantioselectivities of up to 97% ee. This method is applicable to acyclic and heterocyclic amines and was applied toward a five-step synthesis of (R)-piperazic acid.
Subject(s)
Amines/chemistry , Hydrazines/chemistry , Hydroxylamines/chemistry , Pyridazines/chemical synthesis , Catalysis , Kinetics , Palladium/chemistry , Pyridazines/chemistryABSTRACT
[reaction: see text]. Olefin metathesis has been employed in the efficient syntheses of a [2]catenane with the templation being provided by the recognition between a secondary ammonium ion and a crown ether. In one approach, a crown ether precursor has been clipped around an NH2+ center situated in a macrocyclic ring, yielding the mechanically interlocked compound. In the other approach, the reversible nature of olefin metathesis allows for a magic ring synthesis to occur wherein two free macrocycles can be employed as the stationary materials, leading to the formation of the same [2]catenane.